US OptionsDetailed Quotes

XRAY250117C17500

Watchlist

1.25
+0.15+13.64%

15min DelayClose Jan 17 16:00 ET

1.25High1.20Low

Dentsply Sirona Stock Discussion

Moomoo AI

Feb 16, 2024 08:24

The company's low growth and lack of profits have led to a stock price drop. A revenue growth acceleration might boost the share price. However, the real benefit for shareholders will be if the company starts making profits. Despite recent gains, the returns over the last three years have been disappointing.

DENTSPLY SIRONA (NASDAQ:XRAY) Shareholders Have Endured a 32% Loss From Investing in the Stock Three Years Ago

Moomoo AI

Jan 29, 2024 07:51

DENTSPLY SIRONA's decreasing capital employment and flat returns are concerning. The stock's decline may reflect investor pessimism about these trends. The analysis does not see the traits of a multi-bagger in this stock.

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Moomoo AI

Dec 24, 2023 08:55

DENTSPLY SIRONA's decision to pay a dividend amidst a reported loss is unsettling. It's not an ideal choice for long-term buy and hold investors.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Goes Ex-Dividend Soon

Moomoo AI

Dec 18, 2023 13:16

Investors predict limited future growth for the company, reflected by its low P/S ratio. The pessimism around its revenue prospect contributes to its undervalued stock.

There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Moomoo AI

Nov 28, 2023 05:33

DENTSPLY SIRONA, currently undervalued with steady price trends, could make a solid investment. Despite modest growth projections, aspects like capital structure and management track record could be behind its undervaluation.

Should You Investigate DENTSPLY SIRONA Inc. (NASDAQ:XRAY) At US$31.48?

Moomoo AI

Nov 10, 2023 09:44

The reversal of DENTSPLY SIRONA's stock downward trend might hinge on its profitability. Accelerated revenue growth could yield share price bounce. However, present indications show a 4% annual shareholder loss over five years.

Loss-making DENTSPLY SIRONA (NASDAQ:XRAY) Sheds a Further US$273m, Taking Total Shareholder Losses to 42% Over 3 Years

Moomoo AI

Oct 20, 2023 08:32

There is concern over the falling ROCE and constant capital utilization, pointing towards a likely state of stagnation for the business. Unless there is an improvement in these areas, this stock might not be the best investment option.

Returns On Capital Signal Difficult Times Ahead For DENTSPLY SIRONA (NASDAQ:XRAY)

Moomoo Breakfast US

Sep 23, 2022 07:59

Columns Today's Pre-Market Stock Movers: QCOM, BA, ROKU, AZN and More

Gapping up
In reaction to earnings/guidance:
• $CalAmp (CAMP.US)$ +0.6%
Other news:
• $Cano Health (CANO.US)$ +6.1% ( $Humana (HUM.US)$ in the running to acquire CANO according to WSJ)
• $Corcept Therapeutics (CORT.US)$ +4.5% (extends deal with Optime Care to March 31 2024)
• $LPL Financial (LPLA.US)$ +4.1% (reports monthly activity for August)
• $Dentsply Sirona (XRAY.US)$ +3% (names new CFO)
• $iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX.US)$ +2.9% (tr...

Moomoo Breakfast US

Jun 2, 2022 07:27

Columns Today's pre-market stock movers: CHWY, PATH, SNAP, HPE and more

Gainers:
• $Repare Therapeutics (RPTX.US)$ +26.4% (announces worldwide license and collaboration agreement with Roche for camonsertib)
• $Chewy (CHWY.US)$+19.8% (Chewy stock soars on earnings. Here's what really mattered)
• $UiPath (PATH.US)$ +11.7% ( reported first-quarter revenue growth of 32% year-over-year to $245.1 million)
• $Pure Storage (PSTG.US)$ +10.6% (In reaction to earnings)
• $Credo Technology (CRDO.US)$ +10.2% (In reaction ...

Analysts Notebook

Jun 2, 2022 05:59

Columns Top upgrades and downgrades on 6/2

Upgrades
• $Agree Realty Corp (ADC.US)$: BofA Securities Upgrades Agree Realty (ADC) to Buy
• $Americold Realty Trust (COLD.US)$: BofA Securities Upgrades to Neutral from Underperform - PT $30 (from $28)
• $Ecolab (ECL.US)$: UBS Upgrades to Buy from Neutral - PT $205 (from $186)
• $Reinsurance Group of America (RGA.US)$: Credit Suisse Upgrades to Neutral from Underperform - PT $122 (from $80)
• $SolarEdge Technologies (SEDG.US)$: Oppenheimer Upgrades to Out...

No comment yet